by Jason Heaviland | Feb 25, 2026
Advancing Untargeted Metabolomics Data Analysis with MassID™ MassID™ is Panome Bio’s identification engine for Next-Generation Metabolomics®, designed to turn complex untargeted metabolomics data into confident metabolite identifications. By evaluating detected...
by Jason Heaviland | Feb 24, 2026
MassID™ Turning Untargeted Data into Confident Discoveries Get a quick overview of how MassID enhances Panome Bio’s true untargeted metabolomics by transforming raw LC-MS/MS data into high-confidence, biologically interpretable metabolite profiles using advanced,...
by Jason Heaviland | Feb 19, 2026
MassID is a computational tool that enables near-complete annotation of untargeted metabolomics datasets by assigning identification probabilities to detected features. Traditional workflows often leave many metabolites unannotated, limiting downstream biological...
by Jason Heaviland | Dec 3, 2025
From Metabolism to Mechanism, Profile PRMT5 Activity in Cancer Profile PRMT5 activity with precise SDMA/ADMA quantification and full methionine cycle coverage. Support inhibitor development, patient stratification, and tumor profiling.
by Jason Heaviland | Dec 2, 2025
Beyond Plaques and Tangles: How Untargeted Metabolomics Detects Distinct Signatures in Alzheimer’s Disease Untargeted metabolomics captures systemic metabolic changes in neurodegenerative diseases, such as Alzheimer’s, identifying altered pathways and...
